Patrick Fortune, PhD
- Vice President, Strategic Innovation Leaders
- Send a Message
Prior to Mass General Brigham, Pat served as Senior General Manager, Portfolio and Commercial Transactions at Cleveland Clinic Innovations. Pat also served as a member of the Clinic’s Innovations Advisory Board for 7 years prior to that. Previously, Dr. Fortune was a venture capitalist and a Partner at Boston Millennia Mass General Brigham, where he successfully invested in early stage life sciences companies. Dr. Fortune has more than 35 years of experience in the healthcare, life sciences and information technology sectors. He has been responsible for nurturing start-up activities from idea to prototype to standalone business throughout his career. He was previously a senior executive at multiple Fortune 500 companies including: President and Chief Operating Officer of New Era of Networks; Vice President at Monsanto; Vice President, at Bristol Myers Squibb; Group President as well VP R&D at Baxter International. Dr. Fortune currently serves on the Board of Directors of Parexel International Corp, a global $2.5 billion Contract Research Organization, and has served on the Boards of a number of other public and private life sciences companies. He has also been involved in some 30 M&A transactions from sourcing the company to closing the deal and successfully integrating the result. He holds a BA and a PhD in Physical Chemistry from the University of Wisconsin, an MBA from Northwestern University.